Open AccessAortic valve replacement in a patient with systemic lupus erythematosus
Author(s) -
Bhuvnesh Kansara,
Ajmer Singh,
Anil Karlekar,
Yugal Mishra
Publication year - 2013
Publication title -
journal of anaesthesiology-clinical pharmacology/journal of anaesthesiology clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.466
H-Index - 32
eISSN - 2231-2730
pISSN - 0970-9185
DOI - 10.4103/0970-9185.111656
Subject(s) - medicine , asepsis , intensive care medicine , nephrotoxicity , renal replacement therapy , systemic lupus erythematosus , systemic disease , systemic lupus , disease , surgery , kidney
Valvular heart disease in systemic lupus erythematosus (SLE) is associated with substantial morbidity and mortality. Current therapy includes symptomatic measures and valve replacement. SLE can present major challenges because of accrued organ damage, coagulation defects and complex management regimes. The peri-operative goals are to maintain strict asepsis, avoid use of nephrotoxic drugs and thereby renal insult, and to promote early ambulation post-operatively.